Navigation Links
Global Health Progress Joins WHO and DNDi to Call For Increased Commitments to Fighting Neglected Tropical Diseases
Date:7/8/2008

One billion people suffer from preventable, treatable diseases around the world

Statement by Dr. Paul Antony, medical director Global Health Progress

TOYAKO, Japan, July 8 /PRNewswire-USNewswire/ -- "The worldwide pharmaceutical industry is joining the World Health Organization (WHO) and the Drugs for Neglected Diseases initiative (DNDi) in calling on the G-8 to recognize the importance of neglected diseases as a global health threat and a major strain on the economic viability and educational development of communities worldwide. We urge the G-8 to finance successful treatment and prevention programs, to support innovative strategies that address the challenging health gaps in developing countries, and to fund research and development to develop improved diagnostic, treatment and prevention options.

"Most international attention is focused on HIV/AIDS, tuberculosis, malaria and global health security. However, neglected tropical diseases - most of which are preventable and treatable - remain major causes of death and disability worldwide. These diseases receive less funding and less attention while they decrease productivity, negatively affect quality of life and increase poverty throughout the developing world.

"Partnerships supported by the research-based biopharmaceutical companies have provided billions of dollars in medicines, research and development, supplies, distribution networks and other resources to fight neglected diseases such as river blindness, trachoma, and lymphatic filariasis around the world. In the process, we have lowered the cost for effective treatments and made them available to hundreds of millions of people each year. Companies have also made substantial contributions to building health care capacity in developing countries, and are looking to implement more programs to address remaining gaps in care.

"However, the continuing threat of these diseases, which affect one in six people worldwide, and the lack of access to existing treatment and preventative measures makes it clear that there is more work to do. Involvement by the global community, particularly the countries of the G-8, is necessary to further efforts aimed at meeting the critical health challenges of the developing world."

Further information about efforts by research-based biopharmaceutical companies, please visit http://www.globalhealthprogress.org. For information about neglected tropical diseases, visit WHO at http://www.who.int/neglected_diseases/en/index.html or DNDi at http://www.dndi.org.

About Global Health Progress

The Global Health Progress initiative brings research-based biopharmaceutical companies and global health leaders together to improve health in the developing world. Through meaningful public-private partnerships with others in the field, including policymakers in the developed and developing world, multi-lateral institutions, non-governmental organizations, and academe, we are helping to shape sustainable solutions that improve the health of all people. For more information, please visit http://www.globalhealthprogress.org.


'/>"/>
SOURCE Global Health Progress
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Global Med Technologies(R) Announces U.S. Release of Proven Tissue and Cellular Therapy Product
2. Proposing a New Global Compact for Infectious Diseases
3. The Center for Professional Innovation and Education (CfPIE) Announces a New Global Regulatory Certification Track
4. GRAS Proudly Announces Photometrica Version 2.0. Hailed as a Brilliant Solution for More Productive Astronomical Research by Those Engaged in Photometry Using the Global-Rent-a-scope Telescope Systems
5. Signalife and Heart One Global Research Agree to Merge
6. AEGON and Right To Play Announce Global Partnership
7. MED3OOO and Mitsui & Co. Complete U.S. and Global Healthcare Partnership Agreement
8. National Press Club to Host NEWSMAKER Media Briefing on Global Health and the Infections of Poverty - Neglected Tropical Diseases
9. Chronic Kidney Disease Growing Globally
10. TechTeam Global Announces Formation of a Global Pharmaceutical Center of Excellence
11. Chiltern and EPS INTERNATIONAL Enter Into a Global Partnership
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... ... June 28, 2017 , ... Hayes, Inc., a leading provider ... guest speaker lineup* for its second annual Client Symposium. Joining the symposium this ... Keith Fernandez of Privia Health; and Lisa Tourville of Anthem. , “We ...
(Date:6/28/2017)... ... 2017 , ... The Wharton School’s Aresty Institute of Executive ... kick-off to the fifth annual CEO Connection Mid-Market Convention. , The Wharton ... campus, followed by the two-day convention, which will target C-suite executives in mid-market ...
(Date:6/28/2017)... ... June 28, 2017 , ... Schneider Insurance ... assistance to clients in southern Montana, is announcing a focused charity effort to ... The outreach programs offered by Zoo Montana provide students with current knowledge on ...
(Date:6/27/2017)... (PRWEB) , ... June 27, 2017 , ... ... announced the appointment of Mike Finnegan to the position of Executive Vice President, ... of experience in healthcare technology, telehealth and medical device sales leadership. He has ...
(Date:6/27/2017)... ... June 27, 2017 , ... ... many of the health care industry’s hospitals and provider groups, has announced that ... for select customers. Parasail Health is a San Francisco health-finance startup that has ...
Breaking Medicine News(10 mins):
(Date:6/9/2017)... 2017 AirXpanders, Inc. (ASX: AXP) (AirXpanders or ... manufacture, sale and distribution of the AeroForm® Tissue Expander ... its commercial roll-out in the United States ... one hundred (100) medical institutions and health systems, located ... needle-free alternative for women who choose reconstructive surgery following ...
(Date:6/8/2017)... 2017  StatLab Medical Products ("StatLab" or ... of diagnostic supplies for the anatomic pathology ... Company LP ("Cressey & Company"), a healthcare-focused ... investment in the Company. Cressey & Company ... selling shareholder, Prairie Capital, L.P., with certain ...
(Date:6/5/2017)... The Cincinnati location of ... (NYSE: DPLO), has been awarded a Top Workplaces 2017 ... Results are based on an employee survey administered by WorkplaceDynamics, ... improvement. The survey measures several aspects of workplace culture, including ... ...
Breaking Medicine Technology: